Chen Gang and Wei Tao met with the leaders of Guangzhou Pharmaceutical Group and Kangenbei Pharmaceutical Company.

On September 11, Chen Gang, Secretary of the Autonomous Region Party Committee and Director of the Standing Committee of the Autonomous Region People's Congress, and Wei Tao, Chairman of the Autonomous Region, met in Nanning with Li Xiaojun, Chairman of Guangzhou Pharmaceuticals Group Co., Ltd., and Jiang Yi, Chairman of Zhejiang Kangenbei Pharmaceutical Co., Ltd., who attended the 2025 China-ASEAN Artificial Intelligence Empowering Medical Industry Investment Development Conference in Guangxi. Chen Gang and Wei Tao welcomed Guangzhou Pharmaceuticals Group and Kangenbei Pharmaceutical Company to discuss cooperation and business expansion in Guangxi. Chen Gang stated that Guangxi is the "bridgehead" for China's opening-up and cooperation with ASEAN. We are thoroughly implementing the important requirements of General Secretary Xi Jinping on the work of Guangxi, freeing our minds, innovating and seeking change, strengthening ourselves through the sea, opening up and developing, seizing major opportunities such as the national implementation of the artificial intelligence empowerment construction plan, and the high-level co-construction of the Western Land and Sea New Passage. We are continuously expanding our internal and external opening-up, strengthening cooperation in artificial intelligence with ASEAN countries, actively promoting the development of artificial intelligence in medical and pharmaceutical fields, and developing new productive forces in a targeted manner, striving to compose a chapter of modernization in Guangxi with Chinese characteristics. Guangxi has abundant traditional Chinese medicinal resources and platforms such as the Fangchenggang International Medical Open Trial Zone. Guangzhou Pharmaceuticals Group and Kangenbei Pharmaceutical Company have strong capabilities, and the prospects for cooperation between the two sides are broad. We welcome both companies to invest and expand their businesses in Guangxi, strengthen cooperation in "AI+" medical and pharmaceutical, traditional Chinese medicinal planting, and ZhuangYao pharmaceutical research, actively participate in the construction of the Fangchenggang International Medical Open Trial Zone, join hands to develop the ASEAN medical and pharmaceutical industry market, and achieve mutual benefit and win-win cooperation for common development.